Global Peptide Based Infection Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 116 pages | ID: G74066AC905GEN
GlobalInfoResearch

Abstracts

Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective.

SCOPE OF THE REPORT:

Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market.
The global Peptide Based Infection Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peptide Based Infection Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Peptide Based Infection Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Peptide Based Infection Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Gilead Sciences
• Johnson & Johnson (Janssen)
• Vertex Pharmaceuticals
• Mitsubishi Tanabe Pharma
• Medivir

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Telaprevir
• Sofosbuvir
• Others

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Contents

1 PEPTIDE BASED INFECTION THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Peptide Based Infection Therapeutics
1.2 Classification of Peptide Based Infection Therapeutics by Types
  1.2.1 Global Peptide Based Infection Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Peptide Based Infection Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Telaprevir
  1.2.4 Sofosbuvir
  1.2.5 Others
1.3 Global Peptide Based Infection Therapeutics Market by Application
  1.3.1 Global Peptide Based Infection Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Peptide Based Infection Therapeutics Market by Regions
  1.4.1 Global Peptide Based Infection Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Peptide Based Infection Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Peptide Based Infection Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peptide Based Infection Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Peptide Based Infection Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peptide Based Infection Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Peptide Based Infection Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Gilead Sciences
  2.1.1 Business Overview
  2.1.2 Peptide Based Infection Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Gilead Sciences Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson (Janssen)
  2.2.1 Business Overview
  2.2.2 Peptide Based Infection Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Vertex Pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Peptide Based Infection Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Vertex Pharmaceuticals Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mitsubishi Tanabe Pharma
  2.4.1 Business Overview
  2.4.2 Peptide Based Infection Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Medivir
  2.5.1 Business Overview
  2.5.2 Peptide Based Infection Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Medivir Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PEPTIDE BASED INFECTION THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Peptide Based Infection Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Peptide Based Infection Therapeutics Players Market Share
  3.2.2 Top 10 Peptide Based Infection Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL PEPTIDE BASED INFECTION THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Peptide Based Infection Therapeutics Revenue and Market Share by Regions
4.2 North America Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PEPTIDE BASED INFECTION THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
5.2 USA Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE PEPTIDE BASED INFECTION THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PEPTIDE BASED INFECTION THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
7.2 China Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PEPTIDE BASED INFECTION THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PEPTIDE BASED INFECTION THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL PEPTIDE BASED INFECTION THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Peptide Based Infection Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Peptide Based Infection Therapeutics Market Forecast by Type (2018-2023)
10.3 Telaprevir Revenue Growth Rate (2013-2023)
10.4 Sofosbuvir Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)

11 GLOBAL PEPTIDE BASED INFECTION THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Peptide Based Infection Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Peptide Based Infection Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL PEPTIDE BASED INFECTION THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Peptide Based Infection Therapeutics Market Size Forecast (2018-2023)
12.2 Global Peptide Based Infection Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Peptide Based Infection Therapeutics Picture
Table Product Specifications of Peptide Based Infection Therapeutics
Table Global Peptide Based Infection Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Peptide Based Infection Therapeutics Revenue Market Share by Types in 2017
Figure Telaprevir Picture
Figure Sofosbuvir Picture
Figure Others Picture
Table Global Peptide Based Infection Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Peptide Based Infection Therapeutics Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Peptide Based Infection Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Peptide Based Infection Therapeutics Type and Applications
Table Gilead Sciences Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson (Janssen) Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Type and Applications
Table Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Vertex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Vertex Pharmaceuticals Peptide Based Infection Therapeutics Type and Applications
Table Vertex Pharmaceuticals Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Type and Applications
Table Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Medivir Basic Information, Manufacturing Base and Competitors
Table Medivir Peptide Based Infection Therapeutics Type and Applications
Table Medivir Peptide Based Infection Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Peptide Based Infection Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue Share by Players (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Share by Players in 2016
Figure Global Peptide Based Infection Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Peptide Based Infection Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Peptide Based Infection Therapeutics Revenue Market Share in 2017
Figure Global Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Market Share by Regions in 2017
Figure North America Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
Table North America Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Peptide Based Infection Therapeutics Revenue Market Share by Countries in 2017
Figure USA Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Peptide Based Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Peptide Based Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peptide Based Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Peptide Based Infection Therapeutics Revenue Market Share by Countries in 2017
Figure China Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Peptide Based Infection Therapeutics Revenue by Countries (2013-2018)
Table South America Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Peptide Based Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peptide Based Infection Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peptide Based Infection Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peptide Based Infection Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Peptide Based Infection Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue Share by Type (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Share by Type (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Share by Type in 2017
Table Global Peptide Based Infection Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Peptide Based Infection Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Telaprevir Revenue Growth Rate (2013-2018)
Figure Global Sofosbuvir Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue by Application (2013-2018)
Table Global Peptide Based Infection Therapeutics Revenue Share by Application (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Share by Application (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue Share by Application in 2017
Table Global Peptide Based Infection Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Peptide Based Infection Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Peptide Based Infection Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Peptide Based Infection Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Peptide Based Infection Therapeutics Revenue Market Forecast (2018-2023)